Description: Annuities are presenting ever-greater risks for the direct writers: • Variable annuities with guaranteed minimum and enhanced death benefits and income benefits • Fixed annuities with multi-year rate guarantees are capital intensive • In-force structured settlements have asset portfolios with declining investment yields • The impact to the payout annuity market from lengthening life expectancies From the Record of the Society of Actuaries, Volume 27, No. 3, Session 146 PD of the New Orleans Annual Meeting

Description: Shared savings deals are all the rage these days. Significant numbers of payers and provider groups in many markets around the U.S. want to engage in shared savings contracts covering commercial, Medicare and Medicaid patients. The fundamental question underlying a value-based contract is, for whom is the value accruing? Ostensibly, value is accruing to the sponsor—whether employer or public payer—but should be accruing to the provider as well. Often design flaws in value-based arrangements and contracts and/or the inability to execute in a value-based paradigm diminish the savings that could have accrued, create inequities in value or drive unintended consequences. This presentation will provide attendees with insights into how to design a workable value-based payment initiative, how to educate both payer and provider participants, and how to oversee the initiative’s operations. Specific topics will include: • Attribution logic: prospective, retrospective and the details in between • Risk adjustment: why one model doesn’t fit all arrangements, and even if it does, how do you implement? • Data and reporting: matching business needs to the payer’s willingness to be transparent and provider capabilities • Quality improvement as a component of payment: actionable and tied to the attributed population or just “out there?”

Description: Panelists discuss their practices and experiences implementing risk measurement and management for various health insurance product lines including disability income, long-term care, medical/managed care and group insurance products. From Record of Society of Actuaries, Vol. 30, No. 1., Session 65

Description: From a session at a meeting of the Society of Actuaries held in Las Vegas, NV May 22-24, 2000 This teaching session discusses the available tools for communicating company risk postures to senior management. The focus is on tools that show distributions of results rather than a point estimate.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: This session 75PD of the New Orleans Annual Meeting analyzes derivatives contained in various insurance products and techniques used to hedge the derivative exposure. From the Record of the Society of Actuaries, Volume 27, No. 3, Session 75PD.

Description: Baseline and "what if"/stressed projections of cash flows, financial statements and capital requirements are critical inputs for a range of business purposes: forecasts, risk management, liquidity management, strategic decision making, etc. Forward-looking projections have historically been inefficient and were performed in silos, making it difficult to scale the process as CFOs and CROs ask for more. The presenters discuss challenges of the forecast process and opportunities to meet desired future capabilities. They will also discuss "what if" analysis and ways to support production of forward-looking projections for "what if" analysis in an efficient way.

Description: We will determine the role of risk function in evaluating operational risks associated with the implementation of LDTI and any system conversions. Are all models validated by the risk function before they are productionalized and results used by management to make business decisions? Does the risk function play a part in to assist finance, actuarial and investor relations in communicating changes and volatility resulting from LDTI? If not, should it? We will articulate the role that risk functions play in being part of large transformation from the start as a stakeholder/input provider to subsequently being an independent reviewer (i.e., second Line of defense).

Description: Presented at October 1996 Annual Meeting. This session provides varying perspectives on corporate approaches to the macro management of risk. In this paper, areas such as risk identification, asset/liability management structure, and secular trend analysis will be discussed.

Description: 1997 Valuation Actuary Symposium, Session 18, is the first part for the Practitioners' Forum. The goal of this session is to address some of the major issues and concerns of actuarial managers.